Skip to main content
. 2018 Nov 7;8:16499. doi: 10.1038/s41598-018-34738-4

Table 2.

Number and percent of channel catfish (Ictalurus punctatus) 4-month-old fingerlings with congenital anomalies due to microinjection of three different dosages of gRNAs/Cas9 protein targeting toll/interleukin 1 receptor domain-containing adapter molecule (TICAM 1) gene and rhamnose binding lectin (RBL) gene.

Gene Dosage Number and percent of fingerlings with anomaly* Total number
Absence of eye development Absence of barbel Deformed head Spinal deformity
TICAM1 Low 0 (0%) 0 (0%) 0 (0%) 0 (0%) 50
Medium 0 (0%) 0 (0%) 2 (15.4%) 0 (0%) 13
High 0 (0%) 1 (6.3%) 3 (18.8%) (two were mutated, one was not) 0 (0%) 16
RBL Low 2 (7.7%) 0 (0%) 1 (3.8%) 1 (3.8%) 26
Medium 1 (10%) 0 (0%) 0 (0%) 0 (0%) 10
High 1 (7.7%) 0 (0%) 0 (0%) 0 (0%) 13

Three dosages for each gene were injected including low dosage: 2.5 ng gRNA/7.5 ng Cas9 protein, medium dosage: 5 ng gRNA/15 ng Cas9 protein and high dosage: 7.5 ng gRNA/22.5 ng Cas9 protein. All injected and non-injected 4-month-old control fry were free of any anomalies (see Fig. 3).

*All fingerlings with anomalies were mutated except one from the TICAM 1 high dosage that had head deformity but was not mutated.